Core Insights - Baird Medical Investment Holdings Ltd. has announced the clinical adoption of its Microwave Ablation (MWA) system at Elk Medical, a private endocrinology practice in Brooklyn, New York, marking a significant step in expanding access to minimally invasive thyroid treatments [1][3] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on surgical robotic systems and innovative surgical instruments, with a mission to enhance patient outcomes through precision technology [4] - The company is FDA 510(k)-certified and its solutions are utilized in over 30 prestigious hospitals and clinics across the United States, including Johns Hopkins Hospital and Columbia University Medical Center [4] - Baird Medical is a market leader in China for thyroid microwave ablation devices and consumables, and is expanding its commercial presence in over 20 countries worldwide [4] Clinical Adoption and Economic Viability - Dr. Kazeem, an experienced endocrinologist, has performed nine MWA procedures recently, focusing on large thyroid nodules as a non-surgical treatment option [2] - The initial MWA procedures have been successfully reimbursed by Medicare, indicating potential for broader patient access and economic viability of MWA therapy [3]